Wellcome Trust

Type

Non-Profit

Status

Active

Location

London, United Kingdom

Total investments

121

Average round size

67M

Portfolio companies

85

Rounds per year

1.39

Lead investments

28

Follow on index

0.30

Exits

35

Stages of investment
SeedPrivate EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyDrug DiscoveryHealth CareHealth DiagnosticsMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

Wellcome Trust appeared to be the VC, which was created in 1936. The venture was found in Europe in United Kingdom. The leading representative office of defined VC is situated in the London.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Health Diagnostics, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Instacart, DoorDash, Klarna.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Wellcome Trust, startups are often financed by Sequoia Capital, Kleiner Perkins, ARCH Venture Partners. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Venrock, Abingworth. In the next rounds fund is usually obtained by Novo Holdings, Venrock, ARCH Venture Partners.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2011. Despite it in 2019 the fund had an activity. Opposing the other organizations, this Wellcome Trust works on 2 percentage points less the average amount of lead investments. The real fund results show that this VC is 11 percentage points more often commits exit comparing to other companies. The average startup value when the investment from Wellcome Trust is more than 1 billion dollars. The increased amount of exits for fund were in 2014.

The current fund was established by Sir Henry Wellcome. The overall number of key employees were 1.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
121
Lead investments
28
Exits
35
Rounds per year
1.39
Follow on index
0.30
Investments by industry
  • Biotechnology (84)
  • Health Care (64)
  • Medical (36)
  • Pharmaceutical (36)
  • Therapeutics (21)
  • Show 71 more
Investments by region
  • United States (55)
  • United Kingdom (41)
  • Austria (2)
  • Switzerland (3)
  • Germany (3)
  • Show 8 more
Peak activity year
2009
Number of Unicorns
2
Number of Decacorns
4
Number of Minotaurs
7

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
16
Avg. valuation at time of investment
1B
Group Appearance index
0.70
Avg. company exit year
10
Avg. multiplicator
14.52
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Acesion Pharma 01 Nov 2016 Biotechnology, Medical, Pharmaceutical Early Stage Venture 10M Capital Region of Denmark, Copenhagen, Denmark
Siluria Technologies 27 Sep 2011 Biotechnology, Chemical, Fuel, Nanotechnology Early Stage Venture 20M United States, California, San Francisco
WorkEx 26 Jul 2019 Human Resources, Recruiting Early Stage Venture 4M Karnataka, India, Bengaluru

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.